pheEDIT: A Phase 1, Open-Label, Dose-Escalation Safety and Efficacy Gene Editing Study Evaluating HMI-103 in Adults with Classical PKU

Gerry Shioshita, Jennifer Henrick, Carmella Simiele, et al.